| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.12 | 9e-05 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0005 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.0005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | pluripotin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0008 |